Release date: Wednesday, Nov. 9, 2022 at 7p.m. EST
Audience: All external parties
Oakville, ON, Canada
Nov. 9, 2022
Michael Lio, owner of ATG Pharma Inc., is pleased to announce the immediate appointment of Christopher Fabricius to the role of President and Chief Executive Officer (CEO) of ATG Pharma Inc.
“After many years of foundational building, I believe ATG Pharma is ready to move forward with the benefit of extremely experienced leadership,” says Michael. “Our team has worked closely with Christopher over the last two years, and I have the upmost confidence in him. His efforts have been transformational.”
ATG Pharma Inc. looks forward to building on the successes shared within its team and customers. Christopher is committed to ensuring our vision, mission and values are executed with passion and integrity.
Michael will be redirecting his focus to innovation and development strategic initiatives. He will lead the research and development and engineering teams, as the new vice president, reporting directly to Christopher. Michael will retain ownership status of holdings within ATG Pharma and 6Pak.
The ATG Pharma team has a vision to enable transformative operational effectiveness. We strive to provide our customers with the most advanced, efficient and modular filling systems through innovative, adaptable and smart robotic solutions. The ATG Pharma portfolio of expandable systems allows you to fill confidently.
About Michael Lio
Michael Lio is the founder of ATG Pharma and has more than 20 years of experience in managing and growing the organization. Lio’s passions align with product research and development, engineering, manufacturing readiness and operational effectiveness. Prior to establishing ATG Pharma, Lio held several leadership roles within manufacturing engineering positions across several business sectors: pharmaceutical manufacturing, validation consulting and automotive manufacturing. Lio has over 35 years of equipment and manufacturing systems development, process optimization and cost control experience.
About Christopher Fabricius
Christopher has more than 20 years of senior leadership experience in manufacturing and operational businesses within private and public sectors. Fabricius is the founder and president of a boutique operational consultancy and has worked closely with ATG Pharma for the past two years. Prior to joining the ATG Pharma family, Fabricius held several successive leadership posts within multiple business sectors, including life sciences and medical technology, industrial equipment and components, print media and aerospace distribution. Fabricius brings a unique blend of executive leadership skills and experience focusing on organizational growth, team development, process optimization and cost containment and avoidance. Fabricius graduated in 1996 from the Industrial Design program at the Ontario College of Art and Design University, and from Queen’s Smith School of Business in 2009 with a Masters of Business Administration.
Source: ATG Pharma Inc. Oakville, ON, Canada